Document Detail


The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats.
MedLine Citation:
PMID:  15619120     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
RATIONALE: The metabotropic glutamate (mGlu5) receptor subtype 5 antagonist MPEP attenuates self-administration of numerous drugs of abuse.
OBJECTIVES: The purpose of the present study was to explore whether MPEP-induced decreases in nicotine and cocaine self-administration reflect attenuation of the reinforcing and incentive motivational effects of nicotine and cocaine. The effects of MPEP on breaking points maintained by nicotine, cocaine or food were assessed using a progressive ratio schedule of reinforcement. Breaking points obtained under such schedules are postulated to reflect both the reinforcing and incentive motivational properties of reinforcers.
METHODS: Rats were allowed to respond for nicotine (0.05 mg/kg per infusion, free base), cocaine (0.18 mg/kg per infusion, salt), or food (45 mg pellets) under a progressive ratio schedule of reinforcement. After establishing stable and equivalent levels of responding for all three reinforcers, rats underwent one test session where no rewards were presented to assess the effects of 1-day extinction, similar to 1-day pharmacological-induced extinction, on performance in this schedule. Subsequently, rats were again allowed to respond for nicotine, cocaine or food until reestablishment of stable levels of responding. Then, MPEP (1-9 mg/kg) was administered intraperitoneally according to a within-subjects Latin square design, 30 min prior to the testing sessions.
RESULTS: Responding in the absence of a primary reinforcer was significantly decreased compared to responding under baseline conditions. Further, MPEP decreased break points maintained by nicotine, cocaine and food.
CONCLUSIONS: The mGlu5 receptor is implicated in mediating the reinforcing and incentive motivational properties of nicotine, cocaine and food.
Authors:
Neil E Paterson; Athina Markou
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.     Date:  2004-12-24
Journal Detail:
Title:  Psychopharmacology     Volume:  179     ISSN:  0033-3158     ISO Abbreviation:  Psychopharmacology (Berl.)     Publication Date:  2005 Apr 
Date Detail:
Created Date:  2005-04-11     Completed Date:  2005-10-24     Revised Date:  2014-03-19    
Medline Journal Info:
Nlm Unique ID:  7608025     Medline TA:  Psychopharmacology (Berl)     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  255-61     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cocaine / administration & dosage*
Excitatory Amino Acid Antagonists / pharmacology*
Food
Male
Motivation
Nicotine / administration & dosage*
Pyridines / pharmacology*
Rats
Rats, Wistar
Receptor, Metabotropic Glutamate 5
Receptors, Metabotropic Glutamate / antagonists & inhibitors*
Reinforcement (Psychology)
Self Administration
Grant Support
ID/Acronym/Agency:
DA11946/DA/NIDA NIH HHS; R56 DA011946/DA/NIDA NIH HHS
Chemical
Reg. No./Substance:
0/6-methyl-2-(phenylethynyl)pyridine; 0/Excitatory Amino Acid Antagonists; 0/Pyridines; 0/Receptor, Metabotropic Glutamate 5; 0/Receptors, Metabotropic Glutamate; 54-11-5/Nicotine; I5Y540LHVR/Cocaine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of deletion of gria1 or gria2 genes encoding glutamatergic AMPA-receptor subunits on place p...
Next Document:  Activation of a nitric-oxide-sensitive cAMP pathway with phencyclidine: elevated hippocampal cAMP le...